Inactive Instrument
Prevail Therapeutics Inc. Stock
Stocks
PRVL
US74140Y1010
Biotechnology & Medical Research
| 1 day | -0.09% |
| Manager | Title | Age | Since |
|---|---|---|---|
Emily Minkow
PRN | Corporate Officer/Principal | 43 | 2018-10-31 |
Yong Dai
PRN | Corporate Officer/Principal | 55 | 2019-01-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 1/22/21 | Issuer sale | Chief Executive Officer | 388,939 | 1.1357% | ||
| 1/22/21 | Issuer sale | Director | 37,000 | 0.1080% | ||
| 1/22/21 | OrbiMed Advisors Private Equity
| Tender | Company | 13,822,463 | 40.3599% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.09% | +0.39% | - | - | 788M | |
| -3.00% | +2.27% | +73.26% | +113.08% | 72.12B | |
| -2.28% | +3.06% | +49.39% | +89.22% | 65.85B | |
| +5.12% | +25.22% | +5.13% | -5.23% | 29.28B | |
| +0.55% | +1.64% | -4.63% | +469.35% | 27.47B | |
| -4.71% | +5.29% | +46.03% | +8.97% | 26.7B | |
| -1.79% | +0.52% | +34.33% | -18.21% | 20.06B | |
| +1.82% | -6.67% | +251.36% | +388.91% | 18.22B | |
| -2.79% | +0.10% | +11.32% | +549.69% | 16.4B | |
| +0.73% | +5.54% | +39.99% | +148.64% | 13.4B | |
| Average | -1.51% | +8.36% | +56.24% | +193.83% | 32.17B | |
| Weighted average by Cap. | -2.13% | +9.48% | +54.50% | +154.54% |
Employees
-
